Investigators calculated the relative risk of treatment failure as 60% higher than with fluticasone
alone or fluticasone
sponsored study received open-label inhaled fluticasone
propionate/sal-meterol 100 / 50 mcg b.
OptiNose has now successfully moved two product candidates - sumatriptan for acute migraine and fluticasone
for nasal polyps - into late stage clinical development, demonstrating our expertise in both liquid and powder nasal delivery, and our commitment to developing improved alternatives to existing nasal sprays, tablets and injections," said Peter Miller, Chief Executive Officer of OptiNose.
Djupesland commented, "The results of this study provide preliminary evidence suggesting fluticasone
coupled with OptiNose's technology is an effective and well-tolerated treatment for patients with chronic rhinosinusitis.
In this 6-week, double-blind, comparative study, 592 patients with moderate COPD were randomised to receive either a free combination of tiotropium 18micrograms once daily plus formoterol 12micrograms twice daily (n=297) or a free combination of salmeterol 50micrograms twice daily plus fluticasone
propionate 500micrograms twice daily (n=295).
For the randomized, double-blind study, 34 adults swallowed either a placebo or aerosolized fluticasone
twice a day for six weeks.
Propionate Nasal Spray (FLONASE(R)) will be the first product marketed under this arrangement
SALT LAKE CITY -- The combination of inhaled salmeterol and fluticasone
propionate is the first-ever drug therapy shown to reduce mortality in patients with chronic obstructive pulmonary disease, according to the results of the landmark Towards a Revolution in COPD Health (TORCH) study.
Propionate Nasal Spray (FLONASE([R])) Will Be the First Product Marketed under This Arrangement
Tenders are invited for Supply of Fluticasone
Nasal Spray Containing 50 Mcg Per Dose In 100 Metered Dose Phial.
22 /PRNewswire/ -- Next Safety has developed a proprietary platform that delivers nicotine and a number of other drugs including albuterol and the components of Advair(TM), fluticasone
propionate and salmeterol xinofoate, in air timed to the user's inhalation.
May 10, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle all Hatch-Waxman litigation relating to fluticasone
lotion brought by Nycomed US Inc.